Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where G. Lockwood is active.

Publication


Featured researches published by G. Lockwood.


European Urology | 2014

Prevalence of Inflammation and Benign Prostatic Hyperplasia on Autopsy in Asian and Caucasian Men

Alexandre R. Zlotta; Shin Egawa; Dmitry Pushkar; Alexander Govorov; Takahiro Kimura; Masahito Kido; Hiroyuki Takahashi; C. Kuk; Marta Kovylina; Najla Aldaoud; Neil Fleshner; Antonio Finelli; Laurence Klotz; G. Lockwood; Jenna Sykes; Theodorus van der Kwast

UNLABELLEDnInflammation has been suggested to be involved in the pathogenesis of benign prostatic hyperplasia (BPH). We studied the prevalence of inflammation and BPH in Asian and Caucasian men on prostate glands (n=320) obtained during autopsy in Moscow, Russia (Caucasian men, n=220), and Tokyo, Japan (Asian men, n=100). We correlated the presence and grade of acute inflammation (AI) or chronic inflammation (CI) and BPH. AI, CI, and histologic BPH were analyzed in a blinded fashion using a grading system (0-3). We used the Cochran-Armitage test for associations between the degree of BPH and clinical variables and proportional odds logistic regression models in multivariable analysis. Histologic BPH was observed in a similar proportion of Asian and Caucasian men (p=0.94). CI was found in>70% of men in both the Asian and Caucasian groups (p>0.05). Higher BPH scores were associated with more CI (p<0.001). In multivariate analyses, individuals with CI were 6.8 times more likely to have a higher BPH score than individuals without (p<0.0001). Men included in this study presented at the hospital and their symptomatic status was not known. The prevalence of CI and BPH on autopsy is similar in Asian and Caucasian men despite very different diet and lifestyle. CI is strongly associated in both groups with BPH.nnnPATIENT SUMMARYnIn this study, we looked at the prevalence of inflammation and benign prostatic hyperplasia (BPH) on autopsy in Asian and Caucasian men. We found chronic inflammation in>70% of men on autopsy. More chronic inflammation was associated with more BPH.


International Journal of Radiation Oncology Biology Physics | 2014

Prospective Longitudinal Assessment of Quality of Life for Liver Cancer Patients Treated With Stereotactic Body Radiation Therapy

Jonathan Klein; Laura A. Dawson; Haiyan Jiang; John Kim; Rob Dinniwell; James D. Brierley; Rebecca Wong; G. Lockwood; Jolie Ringash

PURPOSEnTo evaluate quality of life (QoL), an important outcome owing to poor long-term survival, after stereotactic body radiation therapy (SBRT) to the liver.nnnMETHODS AND MATERIALSnPatients (n=222) with hepatocellular carcinoma (HCC), liver metastases, or intrahepatic cholangiocarcinoma and Child-Pugh A liver function received 24-60 Gy of 6-fraction image-guided SBRT. Prospective QoL assessment was completed with the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core-30 (QLQ-C30) and/or Functional Assessment of Cancer Therapy-Hepatobiliary (FACT-Hep, version 4) questionnaires at baseline and 1, 3, 6, and 12 months after treatment. Ten HCC patients with Child-Pugh B liver function were also treated.nnnRESULTSnThe QLQ-C30 was available for 205 patients, and 196 completed the FACT-Hep. No difference in baseline QoL (P = .17) or overall survival (P = .088) was seen between the HCC, liver metastases, and intrahepatic cholangiocarcinoma patients. Appetite loss and fatigue measured by the QLQ-C30 clinically and statistically worsened by 1 month after treatment but recovered by 3 months. At 3 and 12 months after treatment, respectively, the FACT-Hep score had improved relative to baseline in 13%/19%, worsened in 36%/27%, and remained stable in 51%/54%. Using the QLQ-C30 Global Health score, QoL improved in 16%/23%, worsened in 34%/39%, and remained stable in 50%/38% at 3 and 12 months, respectively. Median survival was 17.0 months (95% confidence interval [CI] 12.3-19.8 months). Higher baseline scores on both FACT-Hep and QLQ-C30 Global Health were associated with improved survival. Hazard ratios for death, per 10-unit decrease in QoL, were 0.90 (95% CI 0.83-0.98; P = .001) and 0.88 (95% CI 0.82-0.95; P = .001), respectively. Tumor size was inversely correlated with survival.nnnCONCLUSIONSnLiver SBRT temporarily worsens appetite and fatigue, but not overall QoL. Stereotactic body radiation therapy is well tolerated and warrants comparison against other liver-directed therapies.


Practical radiation oncology | 2014

Assessment of nonrespiratory stomach motion in healthy volunteers in fasting and postprandial states

Barbara Wysocka; Joanne Moseley; Kristy K. Brock; G. Lockwood; Graham Wilson; Anna Simeonov; Masoom A. Haider; C. Menard; Jean-Pierre Bissonnette; Laura A. Dawson; Jolie Ringash

PURPOSEnTo characterize nonrespiratory stomach motion in the fasting state and postprandial.nnnMETHODS AND MATERIALSnTen healthy volunteers underwent 2-dimensional Fiesta cine magnetic resonance imaging studies in 30-second voluntary breath hold, in axial, coronal, and 2 oblique planes while fasting, and 5, 15, 30, 45, and 60 minutes postmeal. Each stomach contour was delineated and sampled with 200 points. Matching points were found for all contours in the same 30-second acquisition. Using deformable parametric analysis (Matlab, version 7.1), mean magnitude, and standard deviation of displacement of each point were determined for each patient. Maximal, minimal, and median population values in 6 cardinal, and in any direction, were calculated.nnnRESULTSnThe median of mean displacements for the baseline position of each point was small and rarely exceeded 1.1 mm; greatest value was 1.6 mm superior-inferior. Median displacement (pooled across time) in the right-left, superior-inferior, and anterior-posterior directions was 0.3 (range, -0.7 to 1.3), 0.8 (-0.4 to 2.4), and 0.3 (-1.1 to 1.6) mm, respectively. Fasting and postprandial standard deviation did not differ.nnnCONCLUSIONSnNonrespiratory stomach displacement is small and stomach position is stable after a small, standard meal. Radiation therapy may be delivered at any time within the first hour after eating without significant compromise of planned planning target volumes.


International Journal of Radiation Oncology Biology Physics | 2006

2110 : Abdominal Organ Motion During Conformal Radiotherapy for Gastric Cancer

Jolie Ringash; B. Wysocka; Z. Kassam; G. Lockwood; Laura A. Dawson; James D. Brierley


European Urology Supplements | 2012

1122 Prevalence of prostate carcinoma and its precursor lesions in Russian Caucasian and Japanese men in autopsy specimens: A prospective comparative international study with central pathology review

A.R. Zlotta; Shin Egawa; Dmitry Pushkar; Alexander Govorov; C. Kuk; Marta Kovylina; Najla Aldaoud; Neil Fleshner; A. Finelli; G. Lockwood; T.H. Van Der Kwast


International Journal of Radiation Oncology Biology Physics | 2005

Abdominal Organ Motion During Conformal Radiation

Z. Kassam; James D. Brierley; Laura A. Dawson; G. Lockwood; G. Perkins; K. Churcher; Jolie Ringash


European Urology Supplements | 2014

890 Prevalence of inflammation and benign prostatic hyperplasia on autopsy in Asian and Caucasian men

A.R. Zlotta; Shin Egawa; Dmitry Pushkar; Alexander Govorov; Takahiro Kimura; Masahito Kido; Hiroyuki Takahashi; C. Kuk; Marta Kovylina; Najla Aldaoud; Neil Fleshner; A. Finelli; L. Klotz; G. Lockwood; Jenna Sykes; T.H. van der Kwast


International Journal of Radiation Oncology Biology Physics | 2008

Stereotactic Body Radiotherapy for Liver Malignancies: Prospective QOL Results

Jolie Ringash; G. Lockwood; Mark Lee; Jun Oh Kim; R. Dinniwell; James D. Brierley; L.A. Dawson


International Journal of Radiation Oncology Biology Physics | 2007

The Truths and Myths of Radiotherapy for Verrucous Carcinoma of Larynx

Shao Hui Huang; G. Lockwood; J. Irish; Jolie Ringash; John Kim; John Waldron; Laura A. Dawson; A. Bayley; Bernard Cummings; Brian O'Sullivan


International Journal of Radiation Oncology Biology Physics | 2006

2118: Correlation Between Liver And Kidney Dose Volume Histograms (DVHs) and Late Toxicity After Adjuvant Radiochemotherapy for Gastric Adenocarcinoma

B. Wysocka; Z. Kassam; G. Lockwood; James D. Brierley; Laura A. Dawson; Jolie Ringash

Collaboration


Dive into the G. Lockwood's collaboration.

Top Co-Authors

Avatar

Jolie Ringash

Princess Margaret Cancer Centre

View shared research outputs
Top Co-Authors

Avatar

James D. Brierley

Princess Margaret Cancer Centre

View shared research outputs
Top Co-Authors

Avatar

Laura A. Dawson

Princess Margaret Cancer Centre

View shared research outputs
Top Co-Authors

Avatar

C. Kuk

Princess Margaret Cancer Centre

View shared research outputs
Top Co-Authors

Avatar

Neil Fleshner

Princess Margaret Cancer Centre

View shared research outputs
Top Co-Authors

Avatar

Z. Kassam

University of Toronto

View shared research outputs
Top Co-Authors

Avatar

Shin Egawa

Jikei University School of Medicine

View shared research outputs
Top Co-Authors

Avatar

Alexander Govorov

Moscow State University of Medicine and Dentistry

View shared research outputs
Top Co-Authors

Avatar

Dmitry Pushkar

Moscow State University of Medicine and Dentistry

View shared research outputs
Top Co-Authors

Avatar

Marta Kovylina

Moscow State University of Medicine and Dentistry

View shared research outputs
Researchain Logo
Decentralizing Knowledge